déjà vu:

Bethany Samuelson Bannow1, Alison Edelman2, Marc Carrier3

  • 1The Hemostasis and Thrombosis Center at Oregon Health & Science University, Portland, Oregon, USA; Division of Hematology/Oncology, Department of Medicine, The Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.

概括

直接口服抗凝剂,如利瓦洛克萨班,已经显示出严重月经出血 (HMB) 的增加率. 目前对新型抗凝血剂的试验,如XI因子抑制剂,需要更好地包括和报告月经期个体的HMB.